Desire thinking as a predictor of drinking status following treatment for alcohol use disorder: A prospective study.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
08 2019
Historique:
received: 29 11 2018
revised: 23 02 2019
accepted: 03 03 2019
pubmed: 12 3 2019
medline: 29 9 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Research has indicated that craving is one of the strongest predictors of treatment outcome and relapse in Alcohol Use Disorders (AUD) but there is little consensus on the factors that may influence its activation and escalation. Research has also shown that desire thinking is an important cognitive process which may exacerbate craving in problem drinkers. The aim of present study was to explore, for the first time, the role of desire thinking in prospectively predicting relapse, craving and binge drinking in patients receiving treatment for AUD. One hundred and thirty-five patients admitted to two rehabilitation centres and two outpatient services for addiction and mental health problems were administered baseline, treatment completion and three months follow-up measures of anxiety and depression, AUD severity, binge drinking frequency, craving and desire thinking. Results indicated that the verbal perseveration component of desire thinking at treatment completion was the only significant predictor of relapse at follow-up over and above baseline AUD severity and binge drinking frequency. Furthermore, the imaginal prefiguration component of desire thinking and craving levels at treatment completion were found to predict craving levels at follow-up independently of AUD severity and binge drinking frequency at baseline. Finally, both the imaginal prefiguration and verbal perseveration components of desire thinking at treatment completion were found to be the only predictors of binge drinking frequency at follow-up independently of AUD severity and binge drinking frequency at baseline. Treatments for AUD should aim to reduce desire thinking in people to enhance clinical outcomes and reduce relapse risk.

Identifiants

pubmed: 30856546
pii: S0306-4603(18)31379-0
doi: 10.1016/j.addbeh.2019.03.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-76

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Francesca Martino (F)

Dipartimento di Scienze Biomediche e NeuroMotorie, Università di Bologna, Bologna, Italy; Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK; Studi Cognitivi, sedi di Milano, S. Benedetto del Tronto, Genova, Italy.

Gabriele Caselli (G)

Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK; Studi Cognitivi, sedi di Milano, S. Benedetto del Tronto, Genova, Italy; Sigmund Freud University, Milano, Italy.

Elena Fiabane (E)

Studi Cognitivi, sedi di Milano, S. Benedetto del Tronto, Genova, Italy; Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione, Genova, Italy.

Federica Felicetti (F)

Casa di Cura "Villa San Giuseppe", Ascoli Piceno, Italy.

Cecilia Trevisani (C)

Dipartimento di Scienze Biomediche e NeuroMotorie, Università di Bologna, Bologna, Italy.

Marco Menchetti (M)

Dipartimento di Scienze Biomediche e NeuroMotorie, Università di Bologna, Bologna, Italy.

Clarice Mezzaluna (C)

Studi Cognitivi, sedi di Milano, S. Benedetto del Tronto, Genova, Italy.

Sandra Sassaroli (S)

Studi Cognitivi, sedi di Milano, S. Benedetto del Tronto, Genova, Italy.

Ian P Albery (IP)

Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK.

Marcantonio M Spada (MM)

Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK. Electronic address: spadam@lsbu.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH